Impact of MRA Echo Time on Stroke Prevention Therapy in
Pediatric Patients with Sickle Cell Disease
Authors: Parmpreet Dhillon, MD1, Kerry Morrone,
MD2, Kevin Hsu, MD3, William Gomes,
MD, PhD4, Ellen Silver, Ph.D5,
Daniel Lax MD1, Qi Peng, PhD6, Seon
Kyu Lee MD, PhD3, Deepa Manwani,
MD2, William Mitchell, MD2
1Division of Child Neurology, Department of Neurology,
Montefiore Medical Center / Albert Einstein College of Medicine
2 Division of Hematology/Oncology, Department of
Pediatrics, Children’s Hospital at Montefiore, Albert Einstein College
of Medicine
3Division of Neuroradiology, Department of Radiology,
Montefiore Medical Center / Albert Einstein College of Medicine
4Division of Neuroradiology, Department of Radiology,
Westchester Medical Center and New York Medical College
5Division of Academic General Pediatrics, Children’s
Hospital at Montefiore, Albert Einstein College of Medicine
6Department of Radiology, Montefiore Medical Center /
Albert Einstein College of Medicine
Conflict of Interest Statement: The authors have no conflicts of
interest to disclose
Corresponding Author: Parmpreet Dhillon, MD
1410 Pelham Pwy South - Kennedy 316
Bronx, N.Y. 10461
Phone: 718-430-2447
Fax: 216-208-1053
pampreetdhillonmd@gmail.com
Running Title: Impact of MRA TE on SCD Stroke Prevention Therapy
Tables: 2 Figures: 4
MeSH Index Terms: Magnetic Resonance Angiography, artifacts, stroke,
sickle cell, cerebrovascular disease